A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder

BACKGROUND: The N-methyl-d-aspartate glutamate receptor antagonist ketamine, delivered via an intravenous route, has shown rapid antidepressant effects in patients with treatment-resistant depression. The current study was designed to test the safety, tolerability and efficacy of intranasal ketamine...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lapidus, Kyle A.B., Levitch, Cara F., Perez, Andrew M., Brallier, Jess W., Parides, Michael K., Soleimani, Laili, Feder, Adriana, Iosifescu, Dan V., Charney, Dennis S., Murrough, James W.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185009/
https://ncbi.nlm.nih.gov/pubmed/24821196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2014.03.026
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items